Results 1 - 10 of 53 for nilotinib
  1. Nilotinib is used to treat certain types of chronic myeloid leukemia (CML; a type of cancer of ... who cannot take imatinib because of side effects. Nilotinib is also used to treat certain types of ...
  2. Chronic myeloid leukemia is a slow-growing cancer of the blood-forming tissue (bone marrow). Normal bone marrow produces red blood cells (erythrocytes) that carry ...
  3. The ABL1 gene provides instructions for making a protein involved in many processes in cells throughout the body. The ABL1 protein functions as a kinase, ...
  4. The UGT1A1 gene belongs to a family of genes that provide instructions for making enzymes called UDP-glucuronosyltransferases. These enzymes perform a chemical ...
  5. ... with this combination.Talk with your health provider.Nilotinib (Tasigna)Grapefruit juice can increase how much nilotinib the body absorbs. Drinking grapefruit juice while taking ...
  6. Chronic Myeloid Leukemia/Treatments and Therapies ... Chronic Myeloid Leukemia ... National Cancer Institute ... From the National Institutes of Health ... Chronic myelogenous ...
  7. Chronic Myeloid Leukemia/Treatments and Therapies ... Chronic Myeloid Leukemia ... National Cancer Institute ... From the National Institutes of Health ... Chronic myelogenous ...
  8. Treating Chronic Myeloid Leukemia by Phase (American Cancer Society)  
    Chronic Myeloid Leukemia/Treatments and Therapies ... Chronic Myeloid Leukemia ... American Cancer Society ... Treatment options for chronic myeloid leukemia are based ...
  9. Stages of Chronic Myelogenous Leukemia From the National Institutes of Health (National Cancer Institute)  
    Chronic Myeloid Leukemia/Diagnosis and Tests ... Chronic Myeloid Leukemia ... National Cancer Institute ... From the National Institutes of Health ... Chronic myelogenous ...
  10. Chronic Myeloid Leukemia/Start Here ... Chronic Myeloid Leukemia ... National Cancer Institute ... From the National Institutes of Health ... Chronic myelogenous leukemia ...
previous · 1 · 2 · 3 · 4 · 5 · 6 · next